Ona Therapeutics News and Activities

Acquisition, funding and merger involving Ona Therapeutics.

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).

View the org chart displaying its 14 main executives

Most searched biographies at Ona Therapeutics

• Valerie Vanhooren, Chief Executive Officer
• Valerie Calenda, Director
• Joël Jean-Mairet, Director

Create your alert
to follow the executive moves at Ona Therapeutics.

Ona Therapeutics has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Ona Therapeutics

Social media about Ona Therapeutics

• Ona Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ona Therapeutics on LinkedIn, X (Twitter) & YouTube